UY31930A - Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante - Google Patents

Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante

Info

Publication number
UY31930A
UY31930A UY0001031930A UY31930A UY31930A UY 31930 A UY31930 A UY 31930A UY 0001031930 A UY0001031930 A UY 0001031930A UY 31930 A UY31930 A UY 31930A UY 31930 A UY31930 A UY 31930A
Authority
UY
Uruguay
Prior art keywords
recombinant
pestivirus
bdv
bvdv
csfv
Prior art date
Application number
UY0001031930A
Other languages
English (en)
Inventor
Meyers Gregor
Eva-Maria Schuermann
Birke Andrea Tews
Original Assignee
Boheringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boheringer Ingelheim Pharma Kg filed Critical Boheringer Ingelheim Pharma Kg
Publication of UY31930A publication Critical patent/UY31930A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24362—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a pestivirus atenuados recombinantes, en particula a CSFV, BVDV o BDV atenuado recombinante, donde dicho pestivirus atenuado recombinante no produce una glicoproteina Ems dimèrica. La presente invención también se refiere a composiciones inmunogénicas que comprenden dicho pestivírus así como a un método para atenuar un pestivirus que comprende la etapa de modifica r la glicoproteina Ems por medio de la deleción, o inserción o sustitución, donde dicha modificación produce una glicoproteina Ems no dimérica.
UY0001031930A 2008-06-25 2009-06-23 Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante UY31930A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08159009 2008-06-25

Publications (1)

Publication Number Publication Date
UY31930A true UY31930A (es) 2010-01-29

Family

ID=39708892

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031930A UY31930A (es) 2008-06-25 2009-06-23 Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante

Country Status (16)

Country Link
US (1) US8895026B2 (es)
EP (1) EP2303320B1 (es)
JP (1) JP5642672B2 (es)
KR (1) KR20110036538A (es)
CN (2) CN103721250A (es)
AR (1) AR072302A1 (es)
AU (1) AU2009264206B2 (es)
BR (1) BRPI0914560A2 (es)
CA (1) CA2729105A1 (es)
CL (1) CL2010001569A1 (es)
CO (1) CO6280496A2 (es)
MX (1) MX2010013437A (es)
NZ (1) NZ589723A (es)
SG (1) SG2014010581A (es)
UY (1) UY31930A (es)
WO (1) WO2009156448A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
CN102399755B (zh) * 2011-09-21 2013-03-20 上海创宏生物科技有限公司 一种猪伪狂犬病毒天然弱毒株c株及其耐热保存方法
CN110563818A (zh) * 2012-08-31 2019-12-13 诺华股份有限公司 用于针对金黄色葡萄球菌的免疫的稳定化的蛋白质
MX2016012840A (es) 2014-03-31 2017-05-09 Boehringer Ingelheim Vetmedica Gmbh Moléculas para transporte de antígeno modular mejoradas y sus usos.
WO2015177369A1 (en) * 2014-05-23 2015-11-26 Boehringer Ingelheim Vetmedica Gmbh Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein
WO2018115474A1 (en) 2016-12-22 2018-06-28 Veterinärmedizinische Universität Wien Isolation of a novel pestivirus causing congenital tremor a
WO2020211801A1 (en) * 2019-04-18 2020-10-22 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Recombinant classical swine fever virus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
US5206163A (en) * 1985-07-08 1993-04-27 Chiron Corporation DNA encoding bovine diarrhea virus protein
DE3752182T2 (de) 1986-01-27 1998-08-06 Syntro Corp Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7179473B2 (en) * 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP0982402A1 (en) 1998-08-14 2000-03-01 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Pestivirus vaccination
US6168942B1 (en) 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
DE10143813A1 (de) 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon
US7135561B2 (en) * 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
NZ538394A (en) * 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
US20040185056A1 (en) * 2003-01-03 2004-09-23 Board Of Regents, University Of Nebraska-Lincoln Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US7361357B2 (en) * 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
DE102004025452A1 (de) * 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers

Also Published As

Publication number Publication date
JP2012530681A (ja) 2012-12-06
CN102076356A (zh) 2011-05-25
CO6280496A2 (es) 2011-05-20
MX2010013437A (es) 2011-01-14
NZ589723A (en) 2013-01-25
JP5642672B2 (ja) 2014-12-17
CA2729105A1 (en) 2009-12-30
AU2009264206B2 (en) 2014-12-18
US20110117126A1 (en) 2011-05-19
EP2303320B1 (en) 2014-09-10
SG2014010581A (en) 2014-05-29
AR072302A1 (es) 2010-08-18
CN103721250A (zh) 2014-04-16
WO2009156448A1 (en) 2009-12-30
EP2303320A1 (en) 2011-04-06
AU2009264206A1 (en) 2009-12-30
BRPI0914560A2 (pt) 2015-12-15
KR20110036538A (ko) 2011-04-07
US8895026B2 (en) 2014-11-25
CL2010001569A1 (es) 2011-09-16

Similar Documents

Publication Publication Date Title
UY31930A (es) Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CL2009000707A1 (es) Composicion controladora de enfermedades de plantas que comprende un compuesto derivado de pirazolinona y al menos otros fungicidas derivados de estrobirulina como dimoxiestrobina; y metodo para controlar una enfermedad en planta mediante el uso de la composicion.
CL2016002262A1 (es) Composiciones y métodos para modular la expresión de ttr y vhb
CL2011001757A1 (es) Uso de una composicion farmaceutica que comprende un inhibidor de sglt2 (1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofuran-3-iloxi)-bencil]-benceno, para mejorar el control glucemico.
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
CR20110496A (es) Biespecificos anticuerpos anti-her
MX2010002435A (es) Reduccion de infecciones concomitantes en cerdos mediante el uso de antigeno pcv2.
CR20110043A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas
MX2007006179A (es) Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
IN2012DN00829A (es)
BR112014012524A2 (pt) composições compreendendo um componente de estabilidade do prazo de validade
CR20110103A (es) Heteroarilos sustituidos
CL2007001439A1 (es) Metodo continuo para producir extracto de mosto mediante remojado de la malta por de coccion que comprende emplear uno o mas complementos que contienen almidon como una fuente de azucares fermentables.
BR112013001109A2 (pt) composição que contém galacto-oligossacarídeos e método para produzi-la
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
UA105785C2 (uk) Спосіб очищення ліпопептидів
AR059304A1 (es) Procedimientos para tratar perdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb
NI201200069A (es) Composiciones repelentes y enfoques geneticos para controlar huanglongbing
BR112013005434A2 (pt) novo mono-hidrato de derivados de aza-adamantano
TW200728247A (en) Methods for stabilizing ophthalmic compositions
MY185169A (en) Method and composition for enhanced oil recovery based on supercritical carbon dioxide and a nonionic surfactant
SG10201805749QA (en) Substantially animal protein-free recombinant furin and methods for producing same
CL2011000262A1 (es) Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.
EA201070448A1 (ru) Новые композиции на основе таксоидов
CO6470817A2 (es) Cristales de solvato novedosos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190617